Literature DB >> 24362817

Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas.

Arkadiusz Piotrowski1, Jing Xie2, Ying F Liu3, Andrzej B Poplawski3, Alicia R Gomes3, Piotr Madanecki4, Chuanhua Fu3, Michael R Crowley5, David K Crossman5, Linlea Armstrong6, Dusica Babovic-Vuksanovic7, Amanda Bergner8, Jaishri O Blakeley8, Andrea L Blumenthal9, Molly S Daniels10, Howard Feit11, Kathy Gardner12, Stephanie Hurst9, Christine Kobelka13, Chung Lee14, Rebecca Nagy15, Katherine A Rauen14, John M Slopis16, Pim Suwannarat13, Judith A Westman15, Andrea Zanko14, Bruce R Korf17, Ludwine M Messiaen3.   

Abstract

Constitutional SMARCB1 mutations at 22q11.23 have been found in ∼50% of familial and <10% of sporadic schwannomatosis cases. We sequenced highly conserved regions along 22q from eight individuals with schwannomatosis whose schwannomas involved somatic loss of one copy of 22q, encompassing SMARCB1 and NF2, with a different somatic mutation of the other NF2 allele in every schwannoma but no mutation of the remaining SMARCB1 allele in blood and tumor samples. LZTR1 germline mutations were identified in seven of the eight cases. LZTR1 sequencing in 12 further cases with the same molecular signature identified 9 additional germline mutations. Loss of heterozygosity with retention of an LZTR1 mutation was present in all 25 schwannomas studied. Mutations segregated with disease in all available affected first-degree relatives, although four asymptomatic parents also carried an LZTR1 mutation. Our findings identify LZTR1 as a gene predisposing to an autosomal dominant inherited disorder of multiple schwannomas in ∼80% of 22q-related schwannomatosis cases lacking mutation in SMARCB1.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24362817      PMCID: PMC4352302          DOI: 10.1038/ng.2855

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  56 in total

1.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

2.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

3.  Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis.

Authors:  Miriam J Smith; Andrew J Wallace; Naomi L Bowers; Cecilie F Rustad; C Geoff Woods; Guy D Leschziner; Rosalie E Ferner; D Gareth R Evans
Journal:  Neurogenetics       Date:  2012-03-22       Impact factor: 2.660

4.  Evolution and functional impact of rare coding variation from deep sequencing of human exomes.

Authors:  Jacob A Tennessen; Abigail W Bigham; Timothy D O'Connor; Wenqing Fu; Eimear E Kenny; Simon Gravel; Sean McGee; Ron Do; Xiaoming Liu; Goo Jun; Hyun Min Kang; Daniel Jordan; Suzanne M Leal; Stacey Gabriel; Mark J Rieder; Goncalo Abecasis; David Altshuler; Deborah A Nickerson; Eric Boerwinkle; Shamil Sunyaev; Carlos D Bustamante; Michael J Bamshad; Joshua M Akey
Journal:  Science       Date:  2012-05-17       Impact factor: 47.728

5.  AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.

Authors:  Matthew L Bush; Janet Oblinger; Victoria Brendel; Griffin Santarelli; Jie Huang; Elena M Akhmametyeva; Sarah S Burns; Justin Wheeler; Jeremy Davis; Charles W Yates; Abhik R Chaudhury; Samuel Kulp; Ching-Shih Chen; Long-Sheng Chang; D Bradley Welling; Abraham Jacob
Journal:  Neuro Oncol       Date:  2011-07-21       Impact factor: 12.300

6.  Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.

Authors:  K D Hadfield; W G Newman; N L Bowers; A Wallace; C Bolger; A Colley; E McCann; D Trump; T Prescott; D G R Evans
Journal:  J Med Genet       Date:  2008-02-19       Impact factor: 6.318

7.  AceView: a comprehensive cDNA-supported gene and transcripts annotation.

Authors:  Danielle Thierry-Mieg; Jean Thierry-Mieg
Journal:  Genome Biol       Date:  2006-08-07       Impact factor: 13.583

8.  CDD: specific functional annotation with the Conserved Domain Database.

Authors:  Aron Marchler-Bauer; John B Anderson; Farideh Chitsaz; Myra K Derbyshire; Carol DeWeese-Scott; Jessica H Fong; Lewis Y Geer; Renata C Geer; Noreen R Gonzales; Marc Gwadz; Siqian He; David I Hurwitz; John D Jackson; Zhaoxi Ke; Christopher J Lanczycki; Cynthia A Liebert; Chunlei Liu; Fu Lu; Shennan Lu; Gabriele H Marchler; Mikhail Mullokandov; James S Song; Asba Tasneem; Narmada Thanki; Roxanne A Yamashita; Dachuan Zhang; Naigong Zhang; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2008-11-04       Impact factor: 16.971

9.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

10.  The SWISS-MODEL Repository and associated resources.

Authors:  Florian Kiefer; Konstantin Arnold; Michael Künzli; Lorenza Bordoli; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2008-10-18       Impact factor: 16.971

View more
  88 in total

1.  Identification of a novel germline SMARCB1 nonsense mutation in a family manifesting both schwannomatosis and unilateral vestibular schwannoma.

Authors:  Jian Wu; Mingxiang Kong; Qing Bi
Journal:  J Neurooncol       Date:  2015-09-05       Impact factor: 4.130

2.  Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.

Authors:  Eric Legius; Hilde Brems
Journal:  Childs Nerv Syst       Date:  2020-06-29       Impact factor: 1.475

3.  Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.

Authors:  Camille Louvrier; Eric Pasmant; Audrey Briand-Suleau; Joëlle Cohen; Patrick Nitschké; Juliette Nectoux; Lucie Orhant; Cécile Zordan; Cyril Goizet; Stéphane Goutagny; Dominique Lallemand; Michel Vidaud; Dominique Vidaud; Michel Kalamarides; Béatrice Parfait
Journal:  Neuro Oncol       Date:  2018-06-18       Impact factor: 12.300

4.  Expanding schwannomatosis phenotype.

Authors:  Panagiotis Ioannidis; Dimitra Mamouli; Nicolaos Foroglou
Journal:  J Neurooncol       Date:  2015-02-08       Impact factor: 4.130

Review 5.  [Hereditary tumor syndromes in neuropathology].

Authors:  C Mawrin
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

6.  Pathogenetics of the RASopathies.

Authors:  William E Tidyman; Katherine A Rauen
Journal:  Hum Mol Genet       Date:  2016-07-12       Impact factor: 6.150

7.  Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.

Authors:  Nicolas -Xavier Bonne; Rabih Aboukais; Marc Baroncini; Audrey Hochart; Pierre Leblond; Franck Broly; Frédérique Dubrulle; Jean-Paul Lejeune; Christophe Vincent
Journal:  Childs Nerv Syst       Date:  2016-10-04       Impact factor: 1.475

8.  The Personal Genome Project Canada: findings from whole genome sequences of the inaugural 56 participants.

Authors:  Miriam S Reuter; Susan Walker; Bhooma Thiruvahindrapuram; Joe Whitney; Iris Cohn; Neal Sondheimer; Ryan K C Yuen; Brett Trost; Tara A Paton; Sergio L Pereira; Jo-Anne Herbrick; Richard F Wintle; Daniele Merico; Jennifer Howe; Jeffrey R MacDonald; Chao Lu; Thomas Nalpathamkalam; Wilson W L Sung; Zhuozhi Wang; Rohan V Patel; Giovanna Pellecchia; John Wei; Lisa J Strug; Sherilyn Bell; Barbara Kellam; Melanie M Mahtani; Anne S Bassett; Yvonne Bombard; Rosanna Weksberg; Cheryl Shuman; Ronald D Cohn; Dimitri J Stavropoulos; Sarah Bowdin; Matthew R Hildebrandt; Wei Wei; Asli Romm; Peter Pasceri; James Ellis; Peter Ray; M Stephen Meyn; Nasim Monfared; S Mohsen Hosseini; Ann M Joseph-George; Fred W Keeley; Ryan A Cook; Marc Fiume; Hin C Lee; Christian R Marshall; Jill Davies; Allison Hazell; Janet A Buchanan; Michael J Szego; Stephen W Scherer
Journal:  CMAJ       Date:  2018-02-05       Impact factor: 8.262

9.  LZTR1 is a regulator of RAS ubiquitination and signaling.

Authors:  Johannes W Bigenzahn; Giovanna M Collu; Felix Kartnig; Melanie Pieraks; Gregory I Vladimer; Leonhard X Heinz; Vitaly Sedlyarov; Fiorella Schischlik; Astrid Fauster; Manuele Rebsamen; Katja Parapatics; Vincent A Blomen; André C Müller; Georg E Winter; Robert Kralovics; Thijn R Brummelkamp; Marek Mlodzik; Giulio Superti-Furga
Journal:  Science       Date:  2018-11-15       Impact factor: 47.728

10.  Expansion of the RASopathies.

Authors:  William E Tidyman; Katherine A Rauen
Journal:  Curr Genet Med Rep       Date:  2016-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.